![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
对CD30阳性淋巴瘤的新兴治疗策略
1, Wellington, New Zealand. a.a.boretti@gmail.com.
概括
布伦图西马布维多丁加上环胺,多克索鲁比辛和普雷迪尼松 (BV+CHP) 是CD30阳性淋巴瘤的标准. 本综述探讨了BV+CHP的局限性和新疗法,转向个性化治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 布伦图西马布维多丁 (BV) 改善了CD30表达性淋巴瘤的治疗结果.
- 埃希伦-2试验确立了BV加环胺,多克索鲁比辛和普雷迪尼松 (CHP) 作为全身形大细胞淋巴瘤的前线标准,表现优于CHOP.
- 随着治疗领域的多样化,普遍的BV + CHP方法的局限性正在出现.
研究的目的:
- 批判性地评估支持BV+CHP在CD30阳性淋巴瘤中的证据.
- 探索超越当前护理标准的新型治疗策略.
- 讨论个性化,精确的治疗方法的潜力.
主要方法:
- 对临床试验数据的审查,重点是ECHELON-2试验.
- 评估新兴疗法,包括免疫疗法,向药物和细胞疗法.
- 对复发性/耐药性CD30阳性淋巴瘤的治疗策略的分析.
主要成果:
- 与CHOP相比,BV+CHP在前线系统性形大细胞淋巴瘤中显示出更高的生存率.
- 有证据表明,通用BV+CHP标准存在局限性,需要探索替代方案.
- 新型疗法,包括抗CD30仿真抗原受体 (CAR) -T细胞疗法,显示出对复发性/耐药性疾病的转变潜力.
结论:
- CD30阳性淋巴瘤的治疗正在从一个适合所有人的模式转向个性化策略.
- 优化疗效和最小化毒性是开发新治疗模式的关键目标.
- 未来的方向包括整合基于BV的组合,向药物和先进的细胞疗法,以改善患者的治疗结果和生活质量.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K